Here are relevant reports on : diabetes-care-devices-market
-
US Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Forecast to 2031
The US digital diabetes management market, valued at US$11.19 billion in 2025, stood at US$12.94 billion in 2026 and is projected to advance at a resilient CAGR of 11.9% from 2026 to 2031, culminating in a forecasted valuation of US$22.67 billion by the end of the period. The growth of the US digital diabetes management market is driven by the integration of AI-driven analytics, telehealth platforms, and interoperable ecosystems, which enhance clinical outcomes and patient engagement.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Forecast to 2031
The Europe digital diabetes management market, valued at USD 6.89 billion in 2025, stood at USD 7.78 billion in 2026 and is projected to advance at a resilient CAGR of 10.0% from 2026 to 2031, culminating in a forecasted valuation of USD12.53 billion by the end of the period. Europe is a significant enabler of digital diabetes management. These devices generate continuous, real-time data that can be integrated into digital platforms for monitoring, alerts, and personalized insights.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Hospitals & Self/Home Healthcare) - Global Forecast to 2028
The global digital diabetes management market, valued at US$16.3 billion in 2022, stood at US$18.9 billion in 2023 and is projected to advance at a resilient CAGR of 13.6% from 2023 to 2028, culminating in a forecasted valuation of US$35.8 billion by the end of the period. The demand for better diabetes care solutions has grown of greater significance as diabetes prevalence has increased.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China
The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.
- Published: April 2010
- Price: $ 4950
- TOC Available:
-
Top 10 Medical Devices Market – (Point of Care Diagnostics, Hemodialysis, Minimally Invasive Surgery, Cataract & Ocular Lens, Patient Monitors) – Global Trends, Developments and Forecasts up till 2015
The global top 10 medical devices market was expected to be worth $164 billion in the year 2010 and is estimated to reach $228 billion by 2015, growing at a CAGR of 6.8% from 2010 to 2015. The cardiovascular devices, orthopedic devices, and diagnostic imaging devices markets are the major revenue generators for the medical devices industry
- Published: June 2011
- Price: $ 4950
- TOC Available:
-
Healthcare Mobility Solutions Market by Products & Services (Mobile Devices, Mobile Apps, Enterprise Platforms), Application (Patient Care, Operations, Workforce Management), End User (Payers, Providers, Patients) - Global Forecast to 2020
The global healthcare mobility solutions market is segmented on the basis of products and services, applications, and end users. Based on products and services, the market is segmented into mobile devices, mobile applications, and enterprise platforms. The mobile devices market covers mobile computers, RFID scanners, barcode scanners, and others. On the basis of applications, the market is classified into patient care management, operations management, and workforce management. By end users, the market is divided into payers, providers, and patients. The global healthcare mobility solutions market is expected to reach $84,817.9 Million by 2020 from $24,335.3 Million in 2015, at a CAGR of about 28.4% from 2015 to 2020.
- Published: May 2015
- Price: $ 4950
- TOC Available:
-
Europe Respiratory Care Device Market Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings)- Regional Forecast to 2031
The europe respiratory care devices market, valued at USD 5.97 billion in 2025, stood at USD 6.33 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of USD 8.96 billion by the end of the period. The key players in the Europe respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), and among other players.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Respiratory Care Device Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), & End User (Hospitals, ASCs) - Forecast to 2031
The Asia Pacific respiratory care devices market is projected to reach USD 8.76 billion by 2031, growing at a CAGR of 8.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) - Global Forecast to 2022
The oxygen therapy equipment market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7% from 2017 to 2022. Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Airway Management Devices Market by Type (Endotracheal tubes, Tracheostomy tube, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Resuscitators), Application (Anesthesia, Emergency medicine), End User (Hospitals, Home care settings) - Global Forecast to 2028
The global airway management devices market, valued at US$1.8 billion in 2022, stood at US$1.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The growth in this market is attributed to the increasing demand for airway management devices in developing countries, the rise in surgical procedures, and the growing prevalence of chronic respiratory diseases such as asthma and COPD.
- Published: April 2023
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
